Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indomethacin in Resistant Monosymptomatic Nocturnal Enuresis
NCT00226122Phase 4Completed
- Sponsor
- Aarhus University
- Start
- Jan 2003
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of indomethacin in Monosymptomatic nocturnal enuresis (MNE) (2 arms), sponsored by Aarhus University. Primary endpoint: Number of dry nights at 7 weeks. Started Jan 2003; status: completed.
02
Drugs
indomethacin
03
Conditions
Monosymptomatic nocturnal enuresis (MNE)
Beyond the preview
Go deeper on NCT00226122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226122.